Can I Get a Michigan Medical Marijuana Card for Tourette's Syndrome?
Neurodevelopmental disorder characterized by chronic motor and vocal tics.
Yes — tourette's syndrome qualifies under the Michigan Medical Marihuana Program
Tourette's syndrome is explicitly listed as a Category C qualifying condition on the Michigan MMMP Physician Certification Form, added during the 2018 expansion. TS is a chronic neurodevelopmental disorder where motor and vocal tics — often combined with comorbid OCD or ADHD — cause meaningful functional and social impairment. First-line treatments (clonidine, antipsychotics, behavioral therapy) help many patients, but treatment-resistant or severely affected patients have limited options, making cannabis a reasonable adjunct to explore.
Common symptoms
- Motor tics (sudden, repetitive movements)
- Vocal tics (sounds, words, coprolalia in some patients)
- Premonitory urges before tics
- Comorbid OCD or ADHD (common)
- Social and occupational impairment from tics
- Sleep disturbance
How medical cannabis may help
THC has been studied specifically for tic reduction in Tourette syndrome, with several small clinical trials from Germany showing reduced tic frequency and severity. The endocannabinoid system modulates basal ganglia circuits implicated in TS pathophysiology. Many TS patients also have comorbid anxiety or OCD that may respond to CBD. Cannabis is typically an adjunct to standard TS treatment in patients with inadequate response to first-line therapy.
Evidence base
Müller-Vahl and colleagues at Hannover Medical School in Germany have conducted the most influential cannabis-in-Tourette research. Two small early RCTs (Müller-Vahl 2002, 2003) showed reductions in tic severity with THC compared to placebo. However, the larger and more recent CANNA-TICS multicenter RCT (Müller-Vahl 2023) did not meet its primary endpoint, so the evidence base remains contested. Cannabis may help selected treatment-resistant patients but is not a first-line therapy.
Michigan certification requirements
Documentation of your Tourette diagnosis from a neurologist, psychiatrist, or other specialist familiar with tic disorders is helpful. A list of treatments tried (clonidine, guanfacine, antipsychotics, behavioral interventions like CBIT) and current tic severity is useful. Pediatric patients require a designated caregiver.
Frequently Asked Questions
- Will cannabis make my tics worse or better?
- For most TS patients in published studies, cannabis (particularly THC) reduces tic frequency and severity. A small minority of patients experience no benefit or worsening — the response is individual. Dr. Vance will discuss dosing strategies to find what works for your case.
- Are there pediatric considerations for Tourette and cannabis?
- Yes. Pediatric cannabis use raises concerns about brain development and is approached cautiously. For minors, Michigan requires a designated caregiver, and the decision to use cannabis is made carefully with input from the pediatric neurology team and family.
- How does the Michigan medical marijuana process work for a minor with Tourette's?
- Patients under 18 can qualify with a designated caregiver, typically a parent. Dr. Vance will discuss the diagnosis, current treatment approaches, and how medical cannabis might complement existing care. Records from your neurologist or psychiatrist speed the evaluation.
- Will the medical marijuana card affect my (or my child's) school records?
- Michigan MMMP data is confidential under MCL 333.26426(h) and is not reported to schools or districts. However, if medical cannabis products need to be administered during the school day, that must be coordinated separately with school administration.
- Does medical cannabis help reduce Tourette's tics?
- Research on cannabis for Tourette's syndrome is preliminary but suggestive — some patients report reduced tic frequency or intensity. However, cannabis is not a first-line treatment for Tourette's, and effectiveness varies widely. Coordination with your treating neurologist or psychiatrist is essential.